- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Anaplastic Large Cell Lymphoma, ALK-negative
Total 7384 results
-
Mansoura UniversityUnknown
-
Massachusetts General HospitalDana-Farber Cancer Institute; Beth Israel Deaconess Medical CenterTerminatedDiffuse Large B Cell LymphomaUnited States
-
Hebei Medical University Fourth HospitalUnknownDiffuse Large B-cell LymphomaChina
-
University Hospital, CaenUnknownDiffuse Large B Cell Lymphoma
-
National Cancer Centre, SingaporeGlaxoSmithKlineCompletedDiffuse Large B-cell LymphomaSingapore
-
Asan Medical CenterWithdrawnDiffuse Large B-cell LymphomaKorea, Republic of
-
Samsung Medical CenterNational Cancer Center, Korea; Asan Medical Center; Korea University; Yonsei University and other collaboratorsCompletedDiffuse Large B-cell LymphomaKorea, Republic of
-
Massachusetts General HospitalNovartis; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical CenterCompletedDiffuse Large B-cell LymphomaUnited States
-
Fudan UniversityTerminated
-
Fondazione Italiana Linfomi ONLUSUnknownDiffuse Large B-cell LymphomaItaly
-
Nantes University HospitalCompletedLymphoma, Large-Cell, DiffuseFrance
-
Fudan UniversityUnknown
-
Lymphoma Study AssociationAmgenCompletedDiffuse Large-Cell LymphomaFrance, Belgium
-
Chulalongkorn UniversityBayerTerminatedDiffuse Large B-cell LymphomaThailand
-
Peking Union Medical College HospitalUnknownDiffuse Large B Cell Lymphoma | Peripheral T-Cell Lymphoma | Lymphoma,Non-Hodgkin
-
Hrain Biotechnology Co., Ltd.Shanghai Zhongshan HospitalRecruitingFollicular Lymphoma | Diffuse Large B-cell Lymphoma | CD19-positiveChina
-
University of Alabama at BirminghamNot yet recruitingLymphoma, Follicular | Lymphoma, B-Cell | Diffuse Large B Cell LymphomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)TerminatedRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell LymphomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | CD20 PositiveUnited States
-
AstraZenecaWithdrawnCore: Relapsed or Refractory Diffuse Large B-Cell Lymphoma | Module 1: Non-GCB Diffuse Large B-Cell Lymphoma
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Transformed Non-Hodgkin Lymphoma | Richter Syndrome | Refractory Transformed Non-Hodgkin Lymphoma | Transformed Follicular Lymphoma to Diffuse Large B-Cell LymphomaUnited States
-
The Lymphoma Academic Research OrganisationActive, not recruitingRefractory Indolent Adult Non-Hodgkin Lymphoma | Refractory Mantle Cell Lymphoma | Diffuse Large B-Cell Lymphoma Refractory | Refractory Transformed B-cell Non-Hodgkin Lymphoma | Refractory Primary Mediastinal Large B-Cell Cell LymphomaFrance
-
National Cancer Institute (NCI)RecruitingHigh Grade B-Cell Lymphoma | Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell LymphomaUnited States
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.Anhui Provincial HospitalUnknownFollicular Lymphoma | B Cell Lymphoma | Mantle Cell Lymphoma | Diffuse Large B Cell Lymphoma | Plasma Cell Neoplasm | Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue | Primary Cutaneous Follicle Centre LymphomaChina
-
University Hospital, MontpellierNot yet recruitingDiffuse Large B Cell Lymphoma
-
Yan Zhang, MDPeking University First Hospital; Chinese PLA General Hospital; Peking University...Recruiting
-
Lars Møller PedersenZealand University Hospital; Weill Medical College of Cornell University; Herlev... and other collaboratorsNot yet recruitingDiffuse Large B Cell Lymphoma
-
He HuangLeman Biotech Co., LtdRecruitingDiffuse Large B-cell LymphomaChina
-
Huazhong University of Science and TechnologyRecruitingDiffuse Large B Cell LymphomaChina
-
AstraZenecaHospital Israelita Albert EinsteinRecruitingDiffuse Large B Cell LymphomaBrazil
-
Peng LiuRecruitingDiffuse Large B Cell LymphomaChina
-
Liaoning Tumor Hospital & InstituteNot yet recruitingDiffuse Large B Cell LymphomaChina
-
Zhao WeiliNot yet recruitingDiffuse Large B-cell LymphomaChina
-
Ruijin HospitalRecruiting
-
The First Affiliated Hospital of Soochow UniversityRecruiting
-
The First Affiliated Hospital with Nanjing Medical...Not yet recruitingDiffuse Large B-cell Lymphoma
-
The First Affiliated Hospital with Nanjing Medical...Not yet recruitingDiffuse Large B-cell Lymphoma
-
University of BolognaIRCCS Azienda Ospedaliero-Universitaria di Bologna; Associazione Italiana per...RecruitingDiffuse Large B Cell LymphomaItaly
-
Centre Henri BecquerelNot yet recruitingDiffuse Large B Cell LymphomaFrance
-
Incyte CorporationRecruitingDiffuse Large B-Cell Lymphoma | Large B-Cell LymphomaCroatia, Serbia, Czechia, Finland, Israel, Romania, Denmark, Hungary, Ireland, Poland, Turkey, Bulgaria, Norway, United Kingdom
-
Ruijin HospitalShanxi Province Cancer Hospital; The First Affiliated Hospital of Anhui Medical... and other collaboratorsRecruiting
-
Ruijin HospitalRecruitingDiffuse Large B Cell LymphomaChina
-
Ruijin HospitalRecruitingDiffuse Large B Cell LymphomaChina
-
MorphoSys AGIqvia Pty LtdRecruitingDiffuse Large B-cell LymphomaUnited States
-
WepromRecruitingDiffuse Large B Cell LymphomaFrance
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingDiffuse Large B-cell LymphomaChina
-
Nanfang Hospital of Southern Medical UniversityNot yet recruitingDiffuse Large B Cell LymphomaChina
-
Wuhan UniversityRecruitingDiffuse Large B-cell LymphomaChina
-
Wuhan UniversityRecruitingDiffuse Large B-cell LymphomaChina
-
Karyopharm Therapeutics IncRecruitingDiffuse Large B-cell LymphomaUnited Kingdom, United States, Australia, Austria, Belgium, Bulgaria, Canada, France, Germany, Greece, Hungary, India, Israel, Italy, Netherlands, New Zealand, Poland, Serbia, Spain